A Breakthrough Drug Just Achieved The 'Impossible' For Pancreatic Cancer
Researchers have developed a new drug that targets the KRAS gene mutation, which drives the majority of pancreatic cancer cases. This breakthrough offers hope for significantly improving survival rates for patients with advanced stages of the disease.
Why it matters
Pancreatic cancer has historically been one of the deadliest and most difficult cancers to treat due to its genetic resistance to chemotherapy.
Add ScienceAlert on Google Pancreatic cancer is notoriously difficult to treat because the tumors form a 'fibrotic fortress' that shields them from traditional chemotherapy drugs. (koto_feja/E+/Getty Images) For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.
The article reports on medical research findings in a factual, objective manner without political or social commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in